{{Drugbox
| verifiedrevid = 443493485
| IUPAC_name = [(8''S'',11''R'',13''S'',14''S'',17''R'')-11-[4-(Dimethylamino)phenyl]-17-(2-methoxyacetyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[''a'']phenanthren-17-yl] acetate
| image = Telapristone.svg
| width = 250

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Investigational
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number = 198414-31-2
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 9806190
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 7981950
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1K9EYK92PQ

<!--Chemical data-->
| C=31 | H=39 | N=1 | O=5 
| molecular_weight = 505.65 g/mol
| smiles = O=C5\C=C3/C(=C2/[C@@H](c1ccc(N(C)C)cc1)C[C@@]4([C@@](OC(=O)C)(C(=O)COC)CC[C@H]4[C@@H]2CC3)C)CC5
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C31H39NO5/c1-19(33)37-31(28(35)18-36-5)15-14-27-25-12-8-21-16-23(34)11-13-24(21)29(25)26(17-30(27,31)2)20-6-9-22(10-7-20)32(3)4/h6-7,9-10,16,25-27H,8,11-15,17-18H2,1-5H3/t25-,26+,27-,30-,31-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = JVBGZFRPTRKSBB-MJBQOYBXSA-N
| synonyms= CDB-4124; 17β-(acetyloxy)-11β-[4-(dimethylamino)phenyl]-17α-(2-methoxyacetyl)estra-4,9-dien-3-one
}}

'''Telapristone''' ([[International Nonproprietary Name|INN]]), as '''telapristone acetate''' (proposed brand names '''Proellex''', '''Progenta'''; former code name '''CDB-4124'''), is a [[synthetic compound|synthetic]], [[steroid]]al [[selective progesterone receptor modulator]] (SPRM) related to [[mifepristone]] which is under development by Repros Therapeutics for the treatment of [[breast cancer]], [[endometriosis]], and [[uterine fibroids]].<ref name="AdisInsight">http://adisinsight.springer.com/drugs/800014404</ref><ref name="pmid15120421">{{cite journal | vauthors = Attardi BJ, Burgenson J, Hild SA, Reel JR | title = In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone | journal = J. Steroid Biochem. Mol. Biol. | volume = 88 | issue = 3 | pages = 277–88 | year = 2004 | pmid = 15120421 | doi = 10.1016/j.jsbmb.2003.12.004 | url = }}</ref> It was originally developed by the [[National Institutes of Health]] (NIH), and, as of 2017, is in [[Phases of clinical research|phase II]] [[clinical trial]]s for the aforementioned indications.<ref name="AdisInsight" /> In addition to its activity as an SPRM, the drug also has some [[antiglucocorticoid]] activity.<ref name="pmid24950125">{{cite journal | vauthors = Whitaker LH, Williams AR, Critchley HO | title = Selective progesterone receptor modulators | journal = Curr. Opin. Obstet. Gynecol. | volume = 26 | issue = 4 | pages = 237–42 | year = 2014 | pmid = 24950125 | doi = 10.1097/GCO.0000000000000082 | url = }}</ref>

==See also==
* [[List of investigational hormonal agents#Progestogenics|List of investigational hormonal agents § Progestogenics]]
* [[Aglepristone]]
* [[Lilopristone]]
* [[Onapristone]]
* [[Toripristone]]

==References==
{{Reflist|2}}

==External links==
* [http://adisinsight.springer.com/drugs/800014404 Telapristone - AdisInsight]


{{Progestogens and antiprogestogens}}
{{Progesterone receptor modulators}}
{{Glucocorticoid receptor modulators}}

[[Category:Acetate esters]]
[[Category:Amines]]
[[Category:Antiglucocorticoids]]
[[Category:Estranes]]
[[Category:Ketones]]
[[Category:Selective progesterone receptor modulators]]


{{steroid-stub}}
{{genito-urinary-drug-stub}}